Inducible CO-stimulator molecule, a candidate gene for defective isotype switching, is normal in patients with hyper-IgM syndrome of unknown molecular diagnosis
- 1 November 2003
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 112 (5), 958-964
- https://doi.org/10.1016/s0091-6749(03)02021-9
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Human uracil–DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombinationNature Immunology, 2003
- Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiencyNature Immunology, 2003
- The T cell activation molecule H4 and the CD28-like molecule ICOS are identicalEuropean Journal of Immunology, 2000
- Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)Cell, 2000
- The Emerging Role of CTLA-4 as an Immune AttenuatorImmunity, 1997
- CD28/B7 SYSTEM OF T CELL COSTIMULATIONAnnual Review of Immunology, 1996
- Hyper IgM syndrome associated with defective CD40-mediated B cell activation.Journal of Clinical Investigation, 1994
- The immune responses in CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formationImmunity, 1994
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993
- Immunologic responses to bacteriophage ϕX 174 in immunodeficiency diseasesJournal of Clinical Investigation, 1971